Albert Hay Wah Chan

Title: Albert Hay Wah Chan: Innovator in Cancer Treatment

Introduction

Albert Hay Wah Chan is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancers. His innovative work has led to the filing of a patent that addresses critical health issues.

Latest Patents

Albert Hay Wah Chan holds a patent for "Compositions and methods for inhibition of RAS." This patent includes compounds, salts, esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers, along with pharmaceutical compositions that utilize these compounds. The methods described in the patent focus on modulating, specifically inhibiting, KRAS, particularly the KRAS G12C mutation, to treat various diseases or disorders, including cancers.

Career Highlights

Throughout his career, Albert has worked with prominent organizations such as Leidos Biomedical Research, Inc. and Lawrence Livermore National Security, LLC. His experience in these companies has allowed him to develop and refine his innovative ideas in the biomedical field.

Collaborations

Some of his notable coworkers include Zuhui Zhang and Rui Xu. Their collaborative efforts have contributed to advancements in research and development in the pharmaceutical industry.

Conclusion

Albert Hay Wah Chan's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patent and collaborations highlight his commitment to improving health outcomes through scientific advancements.